Suvaxyn Circo Európai Unió - bolgár - EMA (European Medicines Agency)

suvaxyn circo

zoetis belgium sa - ваксината свинският цирковирус (инактивированных, рекомбинантна) - immunologicals for suidae, inactivated viral vaccines - Свине за угояване) - За активна имунизация на свинете с 3-седмична възраст срещу свинският цирковирус тип 2 (pcv2) за намаляване на вирусния товар в кръвта и от лимфоидни тъкани и фекални избледняват, причинени от инфекция с ЦВС2.

SUVAXYN MH ONE RP ≥ 1 Bulgária - bolgár - БАБХ (Българска агенция по безопасност на храните)

suvaxyn mh one rp ≥ 1

zoetis belgium s.a. - hyopneumoniae микоплазма, инактивированной , щам Р-5722-3 - инжекционна емулсия - rp ≥ 1 - прасета

CircoMax Myco Európai Unió - bolgár - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - Имунологични средства за суици - Свине за угояване) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.